Vaughn Bryan T 4

What Happened
Vaughn Bryan T, EVP and President, Diagnostics at Labcorp (LH), had 327 Restricted Stock Units (RSUs) vest and convert into shares on July 1, 2026. Of those shares, 93 were withheld to satisfy tax obligations (93 @ $283.88, ≈ $26,401) and the remaining 234 shares were sold in the open market on July 2, 2026 at $286.19 per share for proceeds of about $66,968. The RSUs convert with no exercise price.

Key Details

• Transaction dates and prices:
  • 2026-07-01: 327 RSUs vested/converted to 327 shares (no exercise price).
  • 2026-07-01: 93 shares were withheld for taxes at $283.88 (tax withholding; proceeds recorded as $26,401).
  • 2026-07-02: 234 shares sold in open market at $286.19 ($66,968).
• Shares owned after transaction: filing references an aggregate RSU balance (footnote F5); the total shares/RSUs held after these transactions are not specified in the summary data provided.
• Notable footnotes:
  • F1: Each RSU = right to one common share.
  • F2: Withholding used to satisfy tax withholding obligations.
  • F3: Sale executed pursuant to a Rule 10b5-1 plan.
  • F4: These RSUs are from a grant vesting in three equal annual installments beginning July 1, 2026.
  • F5: Aggregate number reflects RSUs held by the reporting person.
• Filing timeliness: no late filing flag indicated in the provided data.

Context
This was a routine vesting and settlement of RSUs, not a cash purchase of stock. The sequence—RSUs vesting, shares withheld for taxes, and the remainder sold (via a 10b5-1 plan)—is a common way executives meet tax obligations and monetize vested equity. These transactions are informational for investors but do not necessarily indicate the insider’s broader view of the company.